Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

AMPA/NMDA receptor antagonists from Rhone-Poulenc Rorer

May 6, 1997

Hyal's Oralease receives Emergency Drug Release status in Canada

May 5, 1997

Synthelabo develops alternative to AChE inhibitors for AD

May 5, 1997

Pierre Fabre prepares agents with antidopaminergic/antiserotonergic effects

May 5, 1997

Preclinical results for N-3389 in emesis

May 5, 1997

Agents specific for dopamine D3 receptors described by Neurogen

May 5, 1997

Delta-opioid receptor ligands reported by SmithKline Beecham

May 5, 1997

CoCensys and Novartis end stroke compound collaboration

May 2, 1997

Neurobiological Technologies initiates second phase II memantine trial

May 2, 1997

Modafinil for sleep apnea-hypopnea syndrome

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...